Genetic Study of Amyotrophic Lateral Sclerosis in Norway (GAIN)

Sykehuset Telemark

Status: Enrolling

Conditions: Amyotrophic Lateral Sclerosis

Treatments: Other: Observation

Study type: Observational

Funder types: Other

Identifiers

NCT05119387

2018/1916

Details and patient eligibility

About

The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.

Full description

After being informed about the study and potential risks, all patients giving written informed consent will be asked to complete a small questionnaire regarding family history and have a blood sample withdrawn. Blood samples, questionnaires, clinical information and signed consent is send to Department of Medical Genetics, Telemark Hospital Trust were the genetic analysis is performed successively throughout the recruitment period. Patients can choose to have their genetic results returned in a diagnostic setting.

Enrollment: 1,200 estimated patients

Sex: All

Ages: 16 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Probable or definite ALS
• Eligible to consent

Exclusion criteria

• not competent to give consent

Trial design

1,200 participants in 1 patient group

Individuals diagnosed with ALS

Description:

Individuals diagnosed with ALS that are being followed through the Norwegian health-care system. ALS patients ( probable or definite per El-Escorial criteria)

Treatment:

Other: Observation